TOKAI PHARMACEUTICALS INC - COM (TKAI)

CUSIP: 88907J107

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
2,783,925
Share change
-2,603,166
Total reported value
$4,256,781
Price per share
$1.53
Number of holders
39
Value change
-$15,521,841
Number of buys
20
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 88907J107?
CUSIP 88907J107 identifies TKAI - TOKAI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TOKAI PHARMACEUTICALS INC - COM (TKAI) as of Q3 2016

As of 30 Sep 2016, TOKAI PHARMACEUTICALS INC - COM (TKAI) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,783,925 shares. The largest 10 holders included BlackRock Fund Advisors, BRIDGEWAY CAPITAL MANAGEMENT INC, SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, NORTHERN TRUST CORP, JPMORGAN CHASE & CO, Emerald Acquisition Ltd., and STATE STREET CORP. This page lists 39 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.